The National Science Council set up the Hsinchu Science Park (HSP), the first establishment of its kind in Taiwan, on December 15, 1980. By ushering in technologies and talent from abroad, bringing about the transformation of domestic conventional industry, and fostering the upgrade of industrial technology across the board, the park is intended to help high-tech industry take off in Taiwan.
Straddling the city and county of Hsinchu, the 6.5-square kilometer HSP now mainly houses semiconductor and optoelectronics ventures. More than 500 tenant companies employ more than 150,000 people. For the past three years, HSP companies posted an annual average of more than NT$1 trillion in revenue, which tends to fluctuate in tandem with the ups and downs in the global economy. Over the years HSP companies have been approved to invest more than NT$1 trillion. The close dependence of tenant companies on the Industrial Technology Research Institute, National Tsing Hua University and National Chiao Tung University can be easily illustrated by the fact that more than 50 of them have emerged as spinoffs from the aforementioned institutions. The high concentration of high-caliber talent at the HSP is only to be expected. Those who are devoted to R&D and technology development account for 40% of the HSP’s overall workforce, with the remaining 60% taken by people engaged in production, management, marketing, etc. In terms of educational levels, around 75% of HSP employees have junior college or higher degrees, which compares with 18% registered by Taiwan’s overall manufacturing sector. Some 57% of HSP employees own a university diploma while the ratio is only 7% for the broader manufacturing sector. Additionally, more than 40,000 master’s degree holders and 3,000 with doctorate degrees now work at the HSP. Of the total, more than 4,000 have returned from abroad to start their own businesses in Taiwan.
Wayne Wang, director general of Hsinchu Science Park (HSP), the country’s largest and oldest innovation cluster and the first in Taiwan to establish a science park exclusively dedicated to the…
The Director General of one of the world’s most successful science parks discusses the history of the park, the reasons behind its incredible success, the unique set-up of the park…
Tung-Mao Su, chairman of TPMA, highlights the association’s historic significance in cultivating Taiwan’s pharmaceutical industry, its members’ most pressing concerns, and outlines the developments of the company which he leads…
Ting-Kuo Lee, Academician of Academia Sinica and chairman of the Taiwan Nanotechnology Industry Development Association, explains the history and mission of the association to promote Taiwan’s nano sector and gives…
HB Chen, president of TaiwanBio Therapeutics, introduces the innovative stem cell company and elaborates on their patented cell expansion technique for the production of mesenchymal stem cells (MSC). Chen then…
Katie Lai, associate director of Medpace Taiwan, introduces the company’s history in Taiwan and highlights the CRO’s unique service offering as a partner of choice to the biotech sector. Lai…
Taiwan boasts a booming life sciences sector and is striving to innovate through collaboration. Here we present five of the key executives and stakeholders who are aiming to drive the…
Albert Lu (founder) and Helen Chiu (co-founder) of Tripod Nano Technology (TPNT), introduce the concept of the original innovative manufacturer (OIM) of metal nanoparticle colloidal solutions and highlight the company’s…
Dr Wen-je Ko, mayor of Taipei City, discusses his plans for creating a key biocluster in the city and goes on to share his views on the government’s role to…
Dr Chien-Huang Lin, tenth president of Taipei Medical University, shares his personal mission upon taking the role, elaborates on the research strengths of TMU, and goes on to discuss the…
Dr Fu-Tong Liu, vice president of Academia Sinica, introduces the institution and its research mission of promoting basic research and enhancing translation. Dr Liu goes on to describe Academia Sinica’s…
Betty Li, managing director of PPC, a well-positioned leader in the APAC CRO landscape, speaks about the strategic significance of the group’s Taiwan affiliate and goes on to share her…
Lily Wu, CEO of PapiVax, discusses the biotechs initiative pipeline for the treatment of HPV related diseases and cancers and goes on to elaborate the company’s development and future partnership…
Luke Chen, co-founder and CEO of PuriBlood, speaks about the innovative spin-off technology developed at the R&D Center for Membrane Technology at Chung Yuan Christian University. The company’s leukocyte reduction…
See our Cookie Privacy Policy Here
